Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Prof Heinz Ludwig talks to ecancer about his presentation at the MyKE20 virtual meeting.
He initially talks about infections in myeloma patients, covering the risks and also management of these infections.
Following on this topic, Prof Ludwig talks about the COVID pandemic risk to myeloma patients.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Advancements in paediatric Acute lymphoblastic leukemia management
Multiple myeloma In Rwanda: The need for further research
Grand Rounds: Improving quality of patient-centred care
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer